Novartis reports positive results for LCZ696 drug to treat chronic heart disease
LCZ696 is a twice a day tablet being investigated for heart failure and is indicated to reduce the strain on the failing heart. The company said that LCZ696
LCZ696 is a twice a day tablet being investigated for heart failure and is indicated to reduce the strain on the failing heart. The company said that LCZ696
In order to solve the problems with our healthcare systems, as well as the patients, we need to look at the healthy that benefit from over the counter
Copaxone is marketed for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS). Multiple sclerosis is a chronic disease of the central nervous system (CNS) characterized by inflammation and neurodegeneration.
Elelyso can now be used as a long-term enzyme replacement therapy (ERT) for the treatment of these patients. Pfizer Global Innovative Pharma Business senior vice-president of Global Medical
The product, which is used to increase female sexual arousal and desire and satisfaction, is approved for marketing in alternative markets which excludes all medical and mainstream sales
The company has already completed the pre-launch preparation of the generic drug and will now be entitled to 180 days of marketing exclusivity under Hatch Waxman rules. According
Currently, PF-06425090 is in Phase II clinical development and it is designed to prevent C. difficile-associated disease, which can include life-threatening diarrhea and pseudomembranous colitis. FDA fast track
The NIH’s $150,000 grant will support the continued preclinical research collaboration between the company and the California Institute for Medical Research (CIMR), which is focused on creating the
The NDA is based on global clinical trial results from the large, multi-center, randomized, double-blind, placebo-controlled, outcomes Phase III Systolic Heart failure treatment with the If inhibitor ivabradine
The vaccine is intended to stimulate the immune system to fight the cancer cells while a PD-1 pathway inhibitor is designed to prevent the cancer cells from camouflaging